ES524815A0 - Procedimiento para la preparacion de un (tio)-eter de 2-metil-liserg-8-ilo - Google Patents

Procedimiento para la preparacion de un (tio)-eter de 2-metil-liserg-8-ilo

Info

Publication number
ES524815A0
ES524815A0 ES524815A ES524815A ES524815A0 ES 524815 A0 ES524815 A0 ES 524815A0 ES 524815 A ES524815 A ES 524815A ES 524815 A ES524815 A ES 524815A ES 524815 A0 ES524815 A0 ES 524815A0
Authority
ES
Spain
Prior art keywords
liserg
ilo
eter
tio
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES524815A
Other languages
English (en)
Other versions
ES8502992A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES8502992A1 publication Critical patent/ES8502992A1/es
Publication of ES524815A0 publication Critical patent/ES524815A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
ES524815A 1982-08-09 1983-08-08 Procedimiento para la preparacion de un (tio)-eter de 2-metil-liserg-8-ilo Granted ES524815A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH4772/82A CH649998A5 (de) 1982-08-09 1982-08-09 Ergolinderivate, ein verfahren zu ihrer herstellung und heilmittel, enthaltend diese ergolinderivate als wirkstoff.

Publications (2)

Publication Number Publication Date
ES8502992A1 ES8502992A1 (es) 1985-02-01
ES524815A0 true ES524815A0 (es) 1985-02-01

Family

ID=4282273

Family Applications (1)

Application Number Title Priority Date Filing Date
ES524815A Granted ES524815A0 (es) 1982-08-09 1983-08-08 Procedimiento para la preparacion de un (tio)-eter de 2-metil-liserg-8-ilo

Country Status (23)

Country Link
JP (1) JPS5948480A (es)
AT (1) AT383125B (es)
AU (1) AU563736B2 (es)
BE (1) BE897473A (es)
CA (1) CA1215972A (es)
CH (1) CH649998A5 (es)
DE (1) DE3327705A1 (es)
DK (1) DK361983A (es)
ES (1) ES524815A0 (es)
FI (1) FI73679C (es)
FR (1) FR2531433B1 (es)
GB (1) GB2125041B (es)
GR (1) GR78923B (es)
HU (1) HU187600B (es)
IL (1) IL69450A (es)
IT (1) IT1168961B (es)
MY (1) MY8700166A (es)
NL (1) NL8302776A (es)
NZ (1) NZ205181A (es)
PH (1) PH20385A (es)
PT (1) PT77168B (es)
SE (1) SE8304315L (es)
ZA (1) ZA835850B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675322A (en) * 1984-12-10 1987-06-23 Eli Lilly And Company 1-Substituted-6-n-propyl-8β-methylthio-methylergolines
HU193782B (en) * 1985-06-21 1987-11-30 Richter Gedeon Vegyeszet Process for producing 2-halogeno-nicergoline derivatives and acid additional salts thereof
FR2589734B1 (fr) * 1985-11-13 1988-09-02 Roussel Uclaf Utilisation de derives de l'ergoline a l'obtention d'un medicament a visee geriatrique
US4798834A (en) * 1987-08-31 1989-01-17 Eli Lilly And Company Optionally substituted (3β-9,10-didehydro-2,3-dihydro ergoline as serotonergic function enhancement
DE3913756A1 (de) * 1989-04-21 1990-10-25 Schering Ag 8(beta)-substituierte ergoline, verfahren zu ihrer herstellung und ihre verwendung
DE10212564B4 (de) * 2002-03-12 2007-04-19 Neurobiotec Gmbh 1-Allyl-ergotalkaloid-Derivate und ihre Verwendung zur Prophylaxe und Therapie von Migräne

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE41533B1 (en) * 1974-03-14 1980-01-30 Sandoz Ltd Thiomethyl ergolene derivatives
US3901894A (en) * 1974-06-06 1975-08-26 Lilly Co Eli 8-thiomethylergolines
US3959288A (en) * 1974-12-13 1976-05-25 Eli Lilly And Company 8-Oxymethylergolines and process therefor
US4166182A (en) * 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds
US4382940A (en) * 1979-12-06 1983-05-10 Farmitalia Carlo Erba S.P.A. Ercoline derivatives and therapeutic compositions having CNS affecting activity

Also Published As

Publication number Publication date
ES8502992A1 (es) 1985-02-01
IT1168961B (it) 1987-05-20
DE3327705A1 (de) 1984-02-09
FR2531433B1 (fr) 1985-10-18
AU1767283A (en) 1984-02-16
SE8304315D0 (sv) 1983-08-08
DK361983D0 (da) 1983-08-08
HU187600B (en) 1986-01-28
BE897473A (fr) 1984-02-06
IL69450A (en) 1986-10-31
FI73679C (fi) 1987-11-09
IL69450A0 (en) 1983-11-30
PT77168A (en) 1983-09-01
PT77168B (en) 1986-03-27
CH649998A5 (de) 1985-06-28
MY8700166A (en) 1987-12-31
GB8321222D0 (en) 1983-09-07
NZ205181A (en) 1986-07-11
AT383125B (de) 1987-05-25
AU563736B2 (en) 1987-07-23
GR78923B (es) 1984-10-02
ATA286383A (de) 1986-10-15
SE8304315L (sv) 1984-02-10
FR2531433A1 (fr) 1984-02-10
FI832789A (fi) 1984-02-10
IT8322490A0 (it) 1983-08-09
CA1215972A (en) 1986-12-30
PH20385A (en) 1986-12-08
GB2125041B (en) 1986-04-23
NL8302776A (nl) 1984-03-01
DK361983A (da) 1984-02-10
JPS5948480A (ja) 1984-03-19
ZA835850B (en) 1985-03-27
FI73679B (fi) 1987-07-31
GB2125041A (en) 1984-02-29
FI832789A0 (fi) 1983-08-02

Similar Documents

Publication Publication Date Title
ES554935A0 (es) Un procedimiento para la preparacion de pirazolo- y piridazo-pirazolinas, -piridazinas y -diacepinas
ES524823A0 (es) Un procedimiento para la preparacion de nuevas fenetanolaminas
ES530714A0 (es) Un procedimiento para la preparacion de un derivado de carbostirilo
ES526295A0 (es) Un procedimiento para la preparacion de derivados de 1-normon-2-ilo
ES531659A0 (es) Un procedimiento para la preparacion de nuevos derivados de arilamida
ES520730A0 (es) Un procedimiento para la prepracion de nuevas benzolactamas.
ES535980A0 (es) Un procedimiento para la preparacion de nuevos derivados de 2-oxo-imidazolina
ES534218A0 (es) Un procedimiento para la preparacion de compuestos de bencimidazol
ES524399A0 (es) Un procedimiento para la preparacion de derivados de milbenicina d
ES530669A0 (es) Un procedimiento para la preparacion de nuevos derivados de fosfolipidos
ES530153A0 (es) Un procedimiento para la preparacion de compuestos de beta-lactama
ES544251A0 (es) Un procedimiento para la preparacion de benzoquinolicinas
ES524815A0 (es) Procedimiento para la preparacion de un (tio)-eter de 2-metil-liserg-8-ilo
ES540343A0 (es) Un procedimiento para la preparacion de derivados de piperi-dina
ES527780A0 (es) Un procedimiento para la preparacion de nuevas espiro-3-azolindionas.
ES529879A0 (es) Un procedimiento para la preparacion de nuevos benzonitrilos
ES527804A0 (es) Un procedimiento para la preparacion de derivados de oxacefalosporina
ES501232A0 (es) Un procedimiento para la preparacion de fenil-quinolicidinas
ES528622A0 (es) Un procedimiento para la preparacion de un acido -hidroxietilfosfinico
ES526400A0 (es) Un procedimiento para la preparacion de pirrolopirroles
ES537782A0 (es) Un procedimiento para la preparacion de 2-cloro-3-trifluorme-tilbenzaldehido
ES526293A0 (es) Un procedimiento para la preparacion de derivados pentaciclicos
ES501277A0 (es) Un procedimiento para la preparacion de perfluoroamidas
ES525961A0 (es) Un procedimiento para la preparacion de a53868 factor a
ES535853A0 (es) Un procedimiento para la preparacion de carboxialquil-dipeptidos